
GV20 Therapeutics and Mitsubishi Tanabe Pharma to Develop Novel Antibody-Drug Conjugates
GV20 Therapeutics (GV20)has entered into a strategic research collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC). Under this collaboration, MTPC will leverage GV20's antibodies, which are specifically directed against novel tumor antigen …